Terms: = Ovarian cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Diagnosis
2 results:
1. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
[TBL] [Abstract] [Full Text] [Related]
2. Multiple primary non-breast tumors in breast cancer survivors.
Corso G; Veronesi P; Santomauro GI; Maisonneuve P; Morigi C; Peruzzotti G; Intra M; Sacchini V; Galimberti V
J Cancer Res Clin Oncol; 2018 May; 144(5):979-986. PubMed ID: 29502170
[TBL] [Abstract] [Full Text] [Related]
